Global shrimp market in 2019 was capitalized at USD 39 billion and projected to develop at a CAGR of 2.5% by the end of 2025.
The global shrimp market value was estimated at 39 (USD Billion) in 2019 and is projected grow at a CAGR of nearly 2.5% during the period from 2019 to 2025. The report offers valuation and analysis of the shrimp market on a global as well as regional level. The study offers a comprehensive assessment of the industry competition, restraints, revenue estimates, avenues, current & emerging trends, and industry-validated market information. The report offers historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on value (USD Billion).
Shrimp is most popular among the traditional sea foods across the globe. According to NCBI, muscle of shrimp contains huge proportion of minerals as well as proteins and low in fats. Apart from this, the lipids of shrimp demonstrate chemo-preventive and chemo-protective features. These are key biological features of this thin food product.
Market Growth Dynamics
Many of the biological events reported for lipid & methanolic extracts from the muscle of the shrimps have the ability to alter biological processes and this has been associated to preventing of cancer in human beings. This beneficial feature of shrimp consumption is likely to drive the demand for shrimps over the upcoming years. Apart from this, the presence of chemopreventive compounds in shrimps offers health benefits to humans as it possesses anti-inflammatory, anti-oxidant, anti-angiogenic, anti-mutagenic, and anti-proliferative characteristics. This is likely to generate he market demand over the coming years.
For instance, anti-oxidants present in shrimps avoid damage of cells through reaction with free radicals along with their elimination from the human body. Furthermore, anti-oxidants have the ability to promote relapse of premalignant injuries along with arresting the growth of premalignant cuts into cancer growth. Furthermore, anti-mutagenic chemo-preventive compounds presence in shrimps provide protection against DNA mutation caused due to mutagenic agents as well as cancer initiation. The anti-proliferative compounds in shrimps slows down the uncontrolled proliferation of cancer cells. Furthermore, the anti-inflammatory feature of shrimps help in preventing the creation of suitable environment for the growth of cancer tumors. Apart from this, anti-angiogenic compounds in shrimps helps in avoiding the cancer cell multiplication through reduction of blood nutrients in the cancer tumors.
Moreover, shrimps are also the source of various carotenoids that also help in cancer prevention. The massive presence of polyunsaturated fatty acids in shrimps have been associated to play a key role in preventing human disorders such as heart ailments. However, though shrimps food comprise of reduced fat content, it consists of high cholesterols levels and this, in turn, is likely to deter the shrimp market expansion over the coming years.
Asia Pacific To Lead Overall Shrimp Market Surge During 2019-2025
The surge in the market in the Asia Pacific zone over the forecast timeline is owing to large-scale shrimp production in countries like China. In addition to this, thriving aquaculture activities in India will majorly contribute towards the regional market expansion over the coming years. Furthermore, countries like China, Thailand, and India are the leading exporters and manufacturers of shrimps.
Key players profiled in the report include Surapon Foods Public Company Limited, Trident Seafood’s Corporation, Nippon Suisan Kaisha, Ltd., and Charoen Pokphand Food PCL.
The global shrimp market is segmented as follows:
By Shrimp Size
By Distribution Channel